Historical record - last NADAC effective date: 4/17/2019
Product Information
BENZTROPINE MES 1 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.0929 per EA under NDC 69097082715. Its NADAC has been published 103 times since May 17, 2017.
FDA first approved this application on Mar 29, 2010.
Strength
1 mg/1
Manufacturer
Cipla USA Inc.NDC
69097082715
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
4/17/2019
Active Ingredients
BENZTROPINE MESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA090294FDA Approved
3/29/2010
On Market Since
6/29/2016
Pharmacological Classes
Price Statistics
The NADAC for BENZTROPINE MES 1 MG TABLET has been published 103 times since May 17, 2017, and over the history we have for it it has declined 18.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0929 per EA |
|---|---|
| All-time high | $0.1133 (Jun 14, 2017) |
| All-time low | $0.0863 (Aug 23, 2017) |
| Median price | $0.1027 |
| Average price | $0.1023 |
| Largest weekly change | +28.8% (Sep 20, 2017) |
| Weeks tracked | 103 |
| Tracking since | May 17, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-18.0%
Last surveyed May 1, 2019 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 19% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cipla USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Benztropine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anticholinergic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BENZTROPINE MES 1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BENZTROPINE MES 1 MG TABLET, manufactured by Cipla USA Inc., is $0.0929 per EA (NDC 69097082715), effective May 1, 2019.
How has the price of BENZTROPINE MES 1 MG TABLET changed over time?
Over the history we have for it, the NADAC for BENZTROPINE MES 1 MG TABLET has declined 18.0%. It has been tracked across 103 weekly CMS publications since May 17, 2017.
What are the highest and lowest recorded NADAC prices for BENZTROPINE MES 1 MG TABLET?
Since May 17, 2017, the NADAC for BENZTROPINE MES 1 MG TABLET has ranged from a low of $0.0863 (Aug 23, 2017) to a high of $0.1133 (Jun 14, 2017), with a median of $0.1027 per EA.
Are there cheaper alternatives to BENZTROPINE MES 1 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BENZTROPINE MES 1 MG TABLET, is $0.0753 per EA — about 19% below BENZTROPINE MES 1 MG TABLET.
Who manufactures BENZTROPINE MES 1 MG TABLET?
BENZTROPINE MES 1 MG TABLET (NDC 69097082715) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.